Education
About Us
Working with TipRanks
Follow Us
ADMA Biologics (ADMA)
NASDAQ:ADMA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 426.45M | $ 258.21M | $ 154.08M | $ 80.94M | $ 42.22M |
| Gross Profit | $ 219.55M | $ 88.94M | $ 35.27M | $ 1.17M | $ -19.07M |
| Operating Income | $ 138.98M | $ 21.63M | $ -39.37M | $ -58.37M | $ -64.91M |
| EBITDA | $ 147.69M | $ 5.12M | $ -39.72M | $ -53.33M | $ -59.82M |
| Net Income | $ 197.67M | $ -28.24M | $ -85.18M | $ -84.45M | $ -87.61M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 103.15M | $ 51.35M | $ 86.52M | $ 51.09M | $ 55.92M |
| Total Assets | $ 488.68M | $ 329.18M | $ 348.46M | $ 276.25M | $ 207.67M |
| Total Debt | $ 82.12M | $ 141.42M | $ 154.44M | $ 102.92M | $ 97.67M |
| Net Debt | $ -21.03M | $ 90.07M | $ 67.92M | $ 51.83M | $ 41.75M |
| Total Liabilities | $ 139.66M | $ 193.98M | $ 196.49M | $ 135.08M | $ 119.42M |
| Stockholders' Equity | $ 349.02M | $ 135.21M | $ 151.97M | $ 141.17M | $ 88.25M |
| Cash Flow | |||||
| Free Cash Flow | $ 110.10M | $ 3.82M | $ -73.42M | $ -125.88M | $ -114.73M |
| Operating Cash Flow | $ 118.67M | $ 8.80M | $ -59.51M | $ -112.37M | $ -102.00M |
| Investing Cash Flow | $ -8.57M | $ -4.98M | $ -13.91M | $ -13.51M | $ -12.72M |
| Financing Cash Flow | $ -58.30M | $ -38.99M | $ 108.85M | $ 121.05M | $ 143.90M |